Cardiologist Roger W. Evans, MD, and his company will pay $1.5 million as settlement in a federal false-claims suit, according to the U.S. Attorneys Office for the District of Kansas.

For the first time, integrated whole-body PET/MR has been demonstrated to be feasible in a clinical setting for diagnostic oncology and produce high quality images comparable to conventional PET/CT, according to a study published in the June issue of the Journal of Nuclear Medicine.

Three-dimensional (3D) digital subtraction angiography (DSA) provides superior detection and delineation of intracranial aneurysms while exposing patients to less radiation, using less contrast and shortening overall procedure time, according to a study published in the June issue of Academic Radiology.

If Julius Genachowski has his way, the U.S. will become the first country in the world to allocate wireless spectrum for medical body area network (MBAN) devices in hospitals, clinics and doctors offices.

On May 17, the FDA approved generic versions of the blood thinning drug clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-Aventis), which helps reduce the risk of heart attack and stroke.

Despite the benefit to lung cancer mortality rates associated with low-dose CT screening as demonstrated by the National Lung Screening Trial, enthusiasm for LDCT should be kept in context. That's because much uncertainty remains about the potential harms of screening and the generalizability of results, according to a review of relevant literature published online May 20 in the Journal of the American Medical Association.

The Breast Imaging Reporting and Data Systems (BI-RADS) MR lexicon helps quantify the likelihood of malignancy for MR-detected lesions, according to a study published online May 15 in Radiology.

Source: Temple UniversityThe line between physical examinations and imaging may be blurring thanks to a tactile imaging sensor prototype which emulates human sensation from a hands-on exam, but also uses LED lights and a camera to quantify the data. Developed by a team of researchers led by Chang-Hee Won, PhD, of Temple University in Philadelphia, the device could help doctors who feel a breast lump during a physical exam, and determine the probability of the lesion being malignant or benign.